Trump and Kennedy Push to Ease Rules on AI Healthcare Tools
Officials in the Trump administration and Robert F. Kennedy Jr. are working to reduce regulatory requirements for artificial intelligence systems used in healthcare, according to reporting from KFF Health News.
The push comes as AI tools proliferate across medical settings, from diagnostic imaging to clinical decision support. Regulators currently require certain AI systems to undergo safety and effectiveness reviews before deployment.
What's at stake
Loosening safeguards could accelerate the introduction of new AI tools to hospitals and clinics. It could also reduce the oversight that currently catches problems before patients are affected.
Healthcare providers have expressed interest in faster access to AI systems that could improve efficiency and reduce costs. Some argue existing approval processes slow innovation unnecessarily.
Regulatory concerns
Medical device regulators have flagged risks with unvetted AI systems, including incorrect diagnoses and biased outputs that affect certain patient populations differently. The FDA and other agencies currently review AI tools for safety before they reach clinical use.
Doctors and patient advocates have warned that weakening these requirements could expose patients to untested systems without adequate evidence of their accuracy or safety.
The broader context
AI adoption in healthcare is accelerating. Recent reports show hospitals deploying systems for tasks ranging from pathology analysis to administrative scheduling. The tension between speed and safety will likely define how these tools are regulated in coming months.
Your membership also unlocks:
